TUTOGEN MEDICAL INC (TTGN) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $82.0K, demonstrating a bearish sentiment with -$82.0K in net insider flow. The most recent transaction on Mar 5, 2007 involved a transaction of 10,000 shares valued at $44.0K.
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 5, 2007 | Cleveland Russell | Executive | Option Exercise | 10,000 | $4.40 | $44.0K | |
| Mar 5, 2007 | Cleveland Russell | Executive | Sale | 10,000 | $8.20 | $82.0K |
No significant insider buying has been recorded for TTGN in the recent period.
No significant insider selling has been recorded for TTGN in the recent period.
Based on recent SEC filings, insider sentiment for TTGN is bearish with an Insider Alignment Score of 0/100 and a net flow of -$82.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at TUTOGEN MEDICAL INC (TTGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading TTGN stock, having executed 2 transactions in the past 90 days. The most active insider is Russell Cleveland (Executive), who has made 2 transactions totaling $126.0K.
Get notified when executives and directors at TTGN file new Form 4 transactions
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 1 | $82.0K | 65.1% |
Exercise(M) | 1 | $44.0K | 34.9% |
Insider selling pressure at TUTOGEN MEDICAL INC has increased, with 1 insiders executing 2 transactions across all time. Total sales of $82.0K significantly outpace purchases of $0, resulting in a net outflow of $82.0K. This selling activity appears largely discretionary, which may warrant closer attention from investors.